Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongmei Han

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
International Journal of Molecular Medicine|October 22, 2014
Profiling of alternative polyadenylation sites in luminal B breast cancer using the SAPAS methodXinmei Wang, Mingyue Li, Yingchun Yin, et al.
Obesity (Silver Spring, Md.)|March 10, 2012
Effect of an environmental school-based obesity prevention program on changes in body fat and body weight: a randomized trialDonald A Williamson, Catherine M Champagne, David W Harsha, et al.
Obesity (Silver Spring, Md.)|April 16, 2011
Change in food cravings, food preferences, and appetite during a low-carbohydrate and low-fat dietCorby K Martin, Diane Rosenbaum, Hongmei Han, et al.
Journal of Translational Medicine|May 8, 2026
Duration-dependent hippocampal structural changes in focal epilepsy: multicenter neuroimaging evidenceYuxin Wu, Zaiyu Zhang, Baohui Yang, et al.
The Journal of Investigative Dermatology|April 27, 2012
The human skin barrier is organized as stacked bilayers of fully extended ceramides with cholesterol molecules associated with the ceramide sphingoid moietyIchiro Iwai, HongMei Han, Lianne den Hollander, et al.
JTO Clinical and Research Reports|June 26, 2025
Patient-Reported Outcomes From LIBRETTO-431: First-Line Selpercatinib Versus Chemotherapy With Pembrolizumab in <i>RET</i> Fusion-Positive NSCLCCaicun Zhou, Silvia Novello, Pilar Garrido, et al.
JTO Clinical and Research Reports|September 22, 2025
First-line Selpercatinib or Chemotherapy and Pembrolizumab in Patients From East Asia With <i>RET</i> Fusion-Positive NSCLC: A LIBRETTO-431 Subgroup AnalysisKoichi Goto, Herbert H Loong, Caicun Zhou, et al.
Military Medicine|February 17, 2009
Military services fitness database: development of a computerized physical fitness and weight management database for the U.S. ArmyDonald A Williamson, Gaston P Bathalon, Lori D Sigrist, et al.
Journal of Behavioral Medicine|October 27, 2009
Adherence is a multi-dimensional construct in the POUNDS LOST trialDonald A Williamson, Stephen D Anton, Hongmei Han, et al.
Frontiers in Oncology|October 4, 2021
Clinical Outcome of CT-Guided Stereotactic Ablative Brachytherapy for Unresectable Early Non-Small Cell Lung Cancer: A Retrospective, Multicenter StudyZhe Ji, Bin Huo, Shifeng Liu, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
International Journal of Molecular Medicine|October 22, 2014
Profiling of alternative polyadenylation sites in luminal B breast cancer using the SAPAS methodXinmei Wang, Mingyue Li, Yingchun Yin, et al.
Obesity (Silver Spring, Md.)|March 10, 2012
Effect of an environmental school-based obesity prevention program on changes in body fat and body weight: a randomized trialDonald A Williamson, Catherine M Champagne, David W Harsha, et al.
Obesity (Silver Spring, Md.)|April 16, 2011
Change in food cravings, food preferences, and appetite during a low-carbohydrate and low-fat dietCorby K Martin, Diane Rosenbaum, Hongmei Han, et al.
Journal of Translational Medicine|May 8, 2026
Duration-dependent hippocampal structural changes in focal epilepsy: multicenter neuroimaging evidenceYuxin Wu, Zaiyu Zhang, Baohui Yang, et al.
The Journal of Investigative Dermatology|April 27, 2012
The human skin barrier is organized as stacked bilayers of fully extended ceramides with cholesterol molecules associated with the ceramide sphingoid moietyIchiro Iwai, HongMei Han, Lianne den Hollander, et al.
JTO Clinical and Research Reports|June 26, 2025
Patient-Reported Outcomes From LIBRETTO-431: First-Line Selpercatinib Versus Chemotherapy With Pembrolizumab in <i>RET</i> Fusion-Positive NSCLCCaicun Zhou, Silvia Novello, Pilar Garrido, et al.
JTO Clinical and Research Reports|September 22, 2025
First-line Selpercatinib or Chemotherapy and Pembrolizumab in Patients From East Asia With <i>RET</i> Fusion-Positive NSCLC: A LIBRETTO-431 Subgroup AnalysisKoichi Goto, Herbert H Loong, Caicun Zhou, et al.
Military Medicine|February 17, 2009
Military services fitness database: development of a computerized physical fitness and weight management database for the U.S. ArmyDonald A Williamson, Gaston P Bathalon, Lori D Sigrist, et al.
Journal of Behavioral Medicine|October 27, 2009
Adherence is a multi-dimensional construct in the POUNDS LOST trialDonald A Williamson, Stephen D Anton, Hongmei Han, et al.
Frontiers in Oncology|October 4, 2021
Clinical Outcome of CT-Guided Stereotactic Ablative Brachytherapy for Unresectable Early Non-Small Cell Lung Cancer: A Retrospective, Multicenter StudyZhe Ji, Bin Huo, Shifeng Liu, et al.
Pageof 9